Volume 44, Issue 1

Search all Journal of Bioenergetics and Biomembranes articles

February 2012

3-Bromopyruvate: A Powerful Small Molecule Anti-Cancer Agent

Issue Editors:

Peter L. Pedersen,
Young H. Ko

23 articles in this issue

3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
Peter L. Pedersen
Editorial 01 March 2012 Pages: 1 - 6
3-bromopyruvate: Targets and outcomes
Maria C. Shoshan
Mini-Review 02 February 2012 Pages: 7 - 15
Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
Simone Cardaci
Enrico Desideri
Maria Rosa Ciriolo
Mini-Review 12 February 2012 Pages: 17 - 29
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate
Ayako Nakano
Hirokazu Miki
Masahiro Abe
OriginalPaper 02 February 2012 Pages: 31 - 38
Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase
Clara Rodrigues-Ferreira
Ana Paula Pereira da Silva
Antonio Galina
OriginalPaper 10 February 2012 Pages: 39 - 49
Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells
Magdalena Davidescu
Miriam Sciaccaluga
Lanfranco Corazzi
OriginalPaper 09 February 2012 Pages: 51 - 60
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
S. M. El Sayed
R. M. Abou El-Magd
K. Fukui
OriginalPaper 09 February 2012 Pages: 61 - 79
Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies
Icard Philippe
Zhang Xiao-Dong
Poulain Laurent
OriginalPaper 10 February 2012 Pages: 81 - 90
Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis
Harrie A. Verhoeven
Leo J. L. D. van Griensven
OriginalPaper Open access 09 February 2012 Pages: 91 - 99
Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition
Su Jong Yu
Jung-Hwan Yoon
Chung Yong Kim
OriginalPaper 15 February 2012 Pages: 101 - 115
Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester
Zhenjie Tang
Shuqiang Yuan
Peng Huang
OriginalPaper 18 February 2012 Pages: 117 - 125
Role of monocarboxylate transporters in human cancers: state of the art
Céline Pinheiro
Adhemar Longatto-Filho
Fátima Baltazar
MINI-REVIEW 10 March 2012 Pages: 127 - 139
Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate
Odília Queirós
Ana Preto
Margarida Casal
OriginalPaper 17 February 2012 Pages: 141 - 153
Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae
Paweł Lis
Marek Zarzycki
Stanisław Ułaszewski
OriginalPaper Open access 23 February 2012 Pages: 155 - 161
A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside
Y. H. Ko
H. A. Verhoeven
P. L. Pedersen
OriginalPaper Open access 11 February 2012 Pages: 163 - 170
Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)
Antônio Talvane Torres de Oliveira
Céline Pinheiro
Fátima Baltazar
OriginalPaper 27 January 2012 Pages: 171 - 178
Protective effect of Phyllanthus fraternus against mitochondrial dysfunction induced by co-administration of cisplatin and cyclophosphamide
Kavita K. Kumari
O. H. Setty
OriginalPaper 24 February 2012 Pages: 179 - 188
ATAD3, a vital membrane bound mitochondrial ATPase involved in tumor progression
Shuijie Li
Denis Rousseau
Mini-Review 09 February 2012 Pages: 189 - 197
Transferring knowledge towards understanding the pore stabilizing variations in K⁺ channels
Mobeen Raja
Nick K. Olrichs
Hildgund Schrempf
Mini-Review 15 February 2012 Pages: 199 - 205
Prerequisites for ubiquinone analogs to prevent mitochondrial permeability transition-induced cell death
Julie Belliere
Flavien Devun
Eric Fontaine
Mini-Review 14 January 2012 Pages: 207 - 212
Subunit F modulates ATP binding and migration in the nucleotide-binding subunit B of the A₁A_O ATP synthase of Methanosarcina mazei Gö1
Devanathan Raghunathan
Shovanlal Gayen
Chandra S. Verma
OriginalPaper 14 February 2012 Pages: 213 - 224
Effects of Lyrm1 knockdown on mitochondrial function in 3 T3-L1 murine adipocytes
Guan-Zhong Zhu
Min Zhang
Xi-Rong Guo
OriginalPaper 15 January 2012 Pages: 225 - 232
Interaction of plant cell signaling molecules, salicylic acid and jasmonic acid, with the mitochondria of Helicoverpa armigera
Akbar S. MD.
H. C. Sharma
Sreeramulu K
OriginalPaper 28 January 2012 Pages: 233 - 241

Volume 44, Issue 1

3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue

3-bromopyruvate: Targets and outcomes

Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug

Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate

Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase

Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells

3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects

Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies

Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis

Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition

Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester

Role of monocarboxylate transporters in human cancers: state of the art

Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate

Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae

A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside

Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)

Protective effect of Phyllanthus fraternus against mitochondrial dysfunction induced by co-administration of cisplatin and cyclophosphamide

ATAD3, a vital membrane bound mitochondrial ATPase involved in tumor progression

Transferring knowledge towards understanding the pore stabilizing variations in K⁺ channels

Prerequisites for ubiquinone analogs to prevent mitochondrial permeability transition-induced cell death

Subunit F modulates ATP binding and migration in the nucleotide-binding subunit B of the A₁A_O ATP synthase of Methanosarcina mazei Gö1

Effects of Lyrm1 knockdown on mitochondrial function in 3 T3-L1 murine adipocytes

Interaction of plant cell signaling molecules, salicylic acid and jasmonic acid, with the mitochondria of Helicoverpa armigera

Navigation